Graphene nanoplatelets (GnPs) offer a promising approach for improving the fracture performance of engineered cementitious composites (ECC); however, their dosage-dependent effects on crack propagation and energy dissipation remain insufficiently understood. This study investigates the fracture behaviour of GnP-modified ECC beams through three-point bending tests on notched specimens and discrete finite element modelling. Four GnP dosages, 0, 0.03, 0.06, and 0.09% by cement weight, were evaluated using the load–crack mouth opening displacement (CMOD) response. The experimental results showed a clear transition from crack initiation to post-peak softening, governed by fibre-bridging mechanisms. GnP dosage significantly influenced peak load, stiffness, residual load capacity, and fracture resistance. The 0.03% GnP mixture exhibited the most favourable performance, with enhanced peak load, stable post-peak softening, and improved fracture process zone stability. In contrast, higher dosages reduced ductility due to changes in crack propagation behaviour. X-ray diffraction and field-emission scanning electron microscopy showed that the 0.03% GnP mixture promoted calcium silicate hydrate formation and produced a denser matrix with well-dispersed nanoplatelets, whereas higher dosages caused localized heterogeneity associated with GnP agglomeration. A two-dimensional finite element model with discrete crack interfaces successfully reproduced the experimental load–CMOD response, including peak load, crack initiation, and post-peak trends. Numerical fracture energy values were consistent with experimental results. Interface opening analysis showed that 0.03% GnP reduced the crack localization amplification ratio from 12.9 to 3.0, indicating suppressed crack localization and improved fracture control.
No takes yet. Share an insight, caveat, or question.
Shams et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: